The Power to Change Lives
September 12, 2018
Sitting Down With… Danny Bar-Zohar, Global Head of Neuroscience Development at Novartis, Switzerland.
1 min read
September 2018
"Industry 4.0 – what does it mean and why should biopharma care? In this month’s cover feature we ask biopharma industry experts for their view. Meanwhile, Upfront looks at a new not-for-profit company headed up by Power List alumni Martin Van Trieste, and a paper-based assay for spotting fake antibiotics. But in In My View, Maarten Van Baelen considers the unintended consequences of fighting counterfeit medicine… Also in this issue we find out what pharma can learn from Toyota in lean manufacturing, and how sharks can influence a new generation of biotherapeutics. Finally, we Sit Down With Danny Bar-Zohar, Global Head of Neuroscience Development at Novartis, Switzerland."
The Medicinal Chemistry Puzzle: Lessons Learned with James Hitchin
September 12, 2018
From big pharma, to cancer research, to joining a fast-growing CRO, James Hitchin has gained multiple perspectives on a subject that has become his passion – medicinal chemistry. Here, he reflects on the changing landscape within the UK, its impact on his career path, and the pitfalls and perks of the field.
1 min read
Antibody About Turn
September 12, 2018
A promising candidate is on the verge of entering clinical development… What happens when you see an opportunity to make it even better? Do you delay – or stick with it in the hope that it’s “good enough”?
1 min read
Kaizen Chiefs
September 12, 2018
Pharma companies have ample room to improve productivity. Lean manufacturing and continuous improvement could be the key to success, and the automotive sector – Toyota, in particular – is a rich source of inspiration.
1 min read
What Makes a “Good” Bioprocess?
September 12, 2018
The development of an optimized bioprocess requires a holistic approach tailored to the specific needs of the product.
1 min read
Towards Industry 4.0
September 12, 2018
The fourth industrial revolution – Industry 4.0 – represents a shift in manufacturing mentality and is driven by intelligent automation, big data, applied machine learning, advanced analytics, and even virtual reality. The digital technology is already here, but is biopharma ready? The third – and final – article in our Biopharma Trends series seeks the answers.
1 min read
Returning to Spain
September 12, 2018
CPhI Worldwide will return on October 9-11, 2018, at the IFEMA, Feria de Madrid, Spain.
1 min read
Right for Patients?
September 12, 2018
“Right to Try” legislation may have compassion at its heart, but it does not do enough to ensure patient protection.
1 min read
The CHO’s Over: An Inflexion Point
September 12, 2018
Global healthcare costs and demands are changing, and the next wave of complex biologics is entering biopharma pipelines. It is time to look beyond mammalian cell lines.
1 min read
The Costs of the Counterfeit Battle
September 12, 2018
Fighting counterfeit medicines is a noble goal, but the financial burden of safety features may affect access to medicines in unintended ways.
1 min read
Business & Regulation
Small Molecules
Formulation
Regulation & Standards
Business & Trends
Sponsored
The Marijuana Medicine Makers
September 12, 2018
Interest in cannabinoid drug development is growing. The potential market – and the opportunity to treat unmet patient needs – is enormous.
1 min read
Manufacture
Bioprocessing
Biopharma
Facilities & Equipment
Technology & Manufacturing
Small Molecules
Trials of a Medicine Maker
September 12, 2018
The secret to tech transfer success...
1 min read
A “Wellcome” Sight
September 12, 2018
A fresh take on an existing photography competition aims to display the diversity of science
1 min read
Business-in-Brief
September 12, 2018
New medicine approvals, a CAR-T rejection in the UK and biosimilar scare tactics… What’s new for pharma in business?
1 min read
Don’t Have Your Fake, or Eat It
September 12, 2018
Finding counterfeit antibiotics – using a color-changing paper test
1 min read
Let’s Talk About Mental Health
September 12, 2018
A recent survey examined the relationships – or lack thereof – between pharma companies and mental health patient groups
1 min read
Knowing Your Values
September 12, 2018
Does a medicine’s price consistently track with its benefits and value? Not in the US, according to a study
1 min read
Just One Shot
September 12, 2018
A vaccine using mRNA demonstrates potential for broad influenza protection
1 min read
Science Versus Sensationalism
September 12, 2018
Don’t give journalists an excuse to fuel the hype machine
1 min read
For Patients, Not Profits
September 7, 2018
A new not-for-profit company will manufacture important generics in the US
1 min read
